{"id":"W2147154643","doi":"10.1517/14712598.7.11.1723","title":"L-BLP25: a MUC1-targeted peptide vaccine therapy in prostate cancer","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta","funders":"","keywords":"Prostate cancer; Medicine; MUC1; Cancer vaccine; Antigen; Cancer; Peptide vaccine; Oncology; Prostate-specific antigen; Immunotherapy; Cancer research; Immunology; Internal medicine; Epitope","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001034422,0.00132978,0.003068623,0.0006985855,0.0002785785,0.00004574902,0.0009997374,0.001811882,0.00439188],"category_scores_gemma":[0.00009521957,0.0007904518,0.00100723,0.0008194683,0.0002866558,0.00009647442,0.00009873851,0.001650013,0.0006828725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002625626,"about_ca_system_score_gemma":0.0002797877,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002287346,"about_ca_topic_score_gemma":0.000004806676,"domain_scores_codex":[0.9936082,0.002184964,0.001577568,0.00125705,0.0001128145,0.001259401],"domain_scores_gemma":[0.9972479,0.001076059,0.0006454399,0.0008817114,0.00008983005,0.00005901143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005192416,0.0007951218,0.00003576288,0.00004184112,0.0006093886,0.0000164045,0.0003785562,3.795872e-7,0.003477925,0.0001027303,0.003308665,0.9860408],"study_design_scores_gemma":[0.004372018,0.002677741,0.0002827969,0.002719254,0.000001320063,0.00006133057,0.00006335142,1.208233e-7,0.001731506,0.00003368065,0.9870396,0.001017256],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001193135,0.9923032,0.000004095953,0.000261607,0.003123985,0.002503464,0.000100948,0.0002525429,0.0002570022],"genre_scores_gemma":[0.0001691435,0.9940962,0.00003177455,0.002049156,0.0003116278,0.001294555,0.001008606,0.00013173,0.000907166],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9850236,"threshold_uncertainty_score":0.9999453,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.124768217387936,"score_gpt":0.3993203044805466,"score_spread":0.2745520870926105,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}